| Bioactivity | SARS-CoV-2 Mpro-IN-35 (compound 14) is a SARS-CoV-2 Mpro inhibitor. SARS-CoV-2 Mpro-IN-35 can be used for the research of SARS-CoV-2 virus[1]. |
| Formula | C22H24Cl3N3OS |
| Molar Mass | 484.87 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Wilders H, et al. Expedited SARS-CoV-2 Main Protease Inhibitor Discovery through Modular 'Direct-to-Biology' Screening. Angew Chem Int Ed Engl. 2024 Dec 4:e202418314. |
SARS-CoV-2 Mpro-IN-35
CAS: F: C22H24Cl3N3OS W: 484.87
SARS-CoV-2 Mpro-IN-35 (compound 14) is a SARS-CoV-2 Mpro inhibitor. SARS-CoV-2 Mpro-IN-35 can be used for the research o
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.